Diagnosis of Transthyretin Amyloid Cardiomyopathy
Abstract Transthyretin amyloid cardiomyopathy (ATTR-CM) continues to be an easily overlooked, life-threatening, yet treatable cause of heart failure. Furthermore, its elusive diagnosis leads to late or misdiagnosis. As therapeutic advancements such as tafamidis usher in a promising new era in the ma...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-04-01
|
Series: | Cardiology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40119-020-00169-4 |